Please enable JavaScript to view the comments powered by Disqus.
Slide Show

1 of 6

5 “Strong Buy” Biotech Stocks to Buy Now

Getty Images


Biotech stocks often present intriguing, and potentially very lucrative, investment opportunities. Share prices can explode on positive trial results or key regulatory approvals.

However, buyers beware: These rewards can disappear just as quickly if critical data disappoints. This is especially the case for biotechnology companies with few or no marketable drugs (and thus they are generating low or even no revenues), especially if their drugs still are in the early stages of development. To minimize this risk, it’s best to search for stocks with a high degree of confidence from Wall Street’s top analysts.

Five compelling biotech stocks stand out as intriguing investing opportunities right now.


We used TipRanks’ Trending Stocks Tool to filter for the best-rated biotechnology stocks over the past few weeks, regardless of market capitalization. All five stocks share a bullish “Strong Buy” analyst consensus rating. And while all five picks have soared over the past three months, word on the Street is that we still have a long way to go.

Let’s delve deeper into these five top biotech companies:

SEE ALSO: 10 Cheap Stocks to Buy With Only $10

Data is as of May 22, 2018. Consensus price targets and ratings based on “Best Performing” analysts. Click on ticker-symbol links in each slide for current share prices and more.


View as One Page

Sponsored Financial Content